| Oligomeric tau-targeted immunotherapy in Tg4510 mice S Schroeder, A Joly-Amado, A Soliman, U Sengupta, R Kayed, ... Alzheimer's Research & Therapy 9, 1-15, 2017 | 16 | 2017 |
| EFhd2 brain interactome reveals its association with different cellular and molecular processes AS Soliman, A Umstead, T Grabinski, NM Kanaan, A Lee, J Ryan, J Lamp, ... Journal of neurochemistry 159 (6), 992-1007, 2021 | 4 | 2021 |
| Validation of recombinant human protein purified from bacteria: An important step to increase scientific rigor A Umstead, AS Soliman, J Lamp, IE Vega Analytical biochemistry 611, 113999, 2020 | 2 | 2020 |
| EFhd2 co-aggregates with monomeric and filamentous tau in vitro AS Soliman, A Umstead, J Lamp, IE Vega Frontiers in Neuroscience 18, 1373410, 2024 | | 2024 |
| Effects of interleukin‐1 receptor antagonist overexpression in a mouse model of tauopathy D Morgan, D FInneran, BG Jackman, AS Soliman, PG Muskus, ... Alzheimer's & Dementia 17, e057694, 2021 | | 2021 |
| P4‐039: A NOVEL HISTONE DEACETYLASE 6 (HDAC6) INHIBITOR TO MITIGATE TAU PATHOLOGY IN ALZHEIMER'S DISEASE MM Alhadidy, AS Soliman, AM Tetlow, B Kara, A Kozikowski, MN Gordon, ... Alzheimer's & Dementia 15, P1289-P1289, 2019 | | 2019 |
| Anti-inflammatory gene therapy as treatment for Alzheimer’s disease in a transgenic mouse model of tauopathy AS Soliman, A Joly-Amado, KR Nash, D Morgan, MN Gordon | | |
